Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation TCT 2022

TCT 389: First Report of Percutaneous Left Atrial Appendage Occlusion with Watchman FLX with TEE Guidance and Zero-contrast

Presenter: Tarun Chakravarty

September 19, 2022

News Conference News TCT 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

Todd Neale

September 18, 2022

Presentation TCT 2022

TCT 387: Saftey of Protamine Adminstration After Percutaneous Left Atrial Appendage Occlusion

Presenter: Ahmed El Shaer

September 18, 2022

Presentation TCT 2022

TCT 386: A Comparative Meta-Analysis of Newer Percutaneous Left Atrial Appendage Occlusion Devices

Presenter: Gauravpal Singh Gill

September 18, 2022

Presentation TCT 2022

TCT 385: Outcomes of Same day Compared to Next day Discharge for Patients Undergoing Left Atrial Appendage Occlusion

Presenter: Riaz Mahmood

September 18, 2022

Presentation TCT 2022

TCT 384: Real-World Practices in the Use of and Adherence to Antithrombotic and Antiplatelet Therapies Before and After Left Atrial Appendage Closure

Presenter: Jennifer Rymer

September 18, 2022

Presentation TCT 2022

TCT 383: Effect of Adding a Novel Coating to the Next-Generation Watchman Device in a Challenging Experimental Animal Model

Presenter: Walid Saliba

September 18, 2022

Presentation TCT 2022

TCT 382: Cardiac Computed Tomographic Assessment of Residual Left Atrial Appendage Patency Following Left Atrial Appendage Closure

Presenter: Sung-Han Yoon

September 18, 2022

Presentation TCT 2022

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Presenter: Davide Cao

September 18, 2022

Presentation TCT 2022

TCT 380: Predicting Device Related Thrombosis Using Computational Fluid Dynamics

Presenter: Brennan Vogl

September 18, 2022

Advertisement

TCT 389: First Report of Percutaneous Left Atrial Appendage Occlusion with Watchman FLX with TEE Guidance and Zero-contrast

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

TCT 387: Saftey of Protamine Adminstration After Percutaneous Left Atrial Appendage Occlusion

TCT 386: A Comparative Meta-Analysis of Newer Percutaneous Left Atrial Appendage Occlusion Devices

TCT 385: Outcomes of Same day Compared to Next day Discharge for Patients Undergoing Left Atrial Appendage Occlusion

TCT 384: Real-World Practices in the Use of and Adherence to Antithrombotic and Antiplatelet Therapies Before and After Left Atrial Appendage Closure

TCT 383: Effect of Adding a Novel Coating to the Next-Generation Watchman Device in a Challenging Experimental Animal Model

TCT 382: Cardiac Computed Tomographic Assessment of Residual Left Atrial Appendage Patency Following Left Atrial Appendage Closure

TCT 381: Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

TCT 380: Predicting Device Related Thrombosis Using Computational Fluid Dynamics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content